Silverarc Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-50,000	Closed	-$2.08M	–	79
2025 Q3	$2.08M	Buy	+50,000	New	+$1.6M	0.3%	61
2024 Q2	–	Sell	-127,835	Closed	-$5.98M	–	76
2024 Q1	$5.98M	Buy	+127,835	New	+$5M	1.68%	23
2023 Q4	–	Sell	-220,000	Closed	-$6.54M	–	77
2023 Q3	$6.54M	Buy	+220,000	New	+$4.53M	2.44%	17
2023 Q1	–	Sell	-152,747	Closed	-$2.8M	–	86
2022 Q4	$2.8M	Buy	152,747 +3,720	+2%	+$65.6K	0.96%	44
2022 Q3	$2.93M	Buy	149,027 +9,488	+7%	+$193K	1.24%	33
2022 Q2	$2.6M	Buy	139,539 +25,535	+22%	+$510K	1.22%	34
2022 Q1	$2.5K	Buy	114,004 +2,144	+2%	+$43.4K	1.18%	25
2021 Q4	$3.18M	Buy	111,860 +62,478	+127%	+$1.54M	1.42%	25
2021 Q3	$1.04M	Buy	+49,382	New	+$1.03M	0.6%	56